Insufficient scRNA-seq data for expression of HCRT at single-cell level.
Insufficient scRNA-seq data for expression of HCRT at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 90% | 599.59 | 2376 / 2642 | 3% | 0.38 | 24 / 705 |
spleen | 77% | 2.42 | 186 / 241 | 0% | 0 | 0 / 0 |
bladder | 67% | 1.38 | 14 / 21 | 5% | 0.13 | 26 / 504 |
intestine | 54% | 1.33 | 517 / 966 | 17% | 0.42 | 88 / 527 |
stomach | 47% | 1.11 | 170 / 359 | 23% | 0.56 | 65 / 286 |
esophagus | 65% | 1.91 | 936 / 1445 | 4% | 0.09 | 7 / 183 |
lung | 58% | 1.51 | 335 / 578 | 2% | 0.05 | 27 / 1155 |
peripheral blood | 57% | 1.67 | 528 / 929 | 0% | 0 | 0 / 0 |
kidney | 54% | 1.30 | 48 / 89 | 2% | 0.06 | 14 / 901 |
adrenal gland | 55% | 1.52 | 143 / 258 | 0% | 0 | 0 / 230 |
adipose | 55% | 1.42 | 662 / 1204 | 0% | 0 | 0 / 0 |
skin | 53% | 1.37 | 960 / 1809 | 0% | 0 | 0 / 472 |
blood vessel | 51% | 1.22 | 682 / 1335 | 0% | 0 | 0 / 0 |
breast | 50% | 1.27 | 228 / 459 | 0% | 0.00 | 2 / 1118 |
uterus | 48% | 1.11 | 81 / 170 | 0% | 0.01 | 2 / 459 |
prostate | 44% | 0.95 | 109 / 245 | 0% | 0.00 | 1 / 502 |
pancreas | 36% | 0.68 | 118 / 328 | 8% | 0.18 | 15 / 178 |
thymus | 42% | 0.94 | 273 / 653 | 1% | 0.01 | 6 / 605 |
ovary | 41% | 0.91 | 74 / 180 | 1% | 0.30 | 5 / 430 |
heart | 34% | 0.73 | 295 / 861 | 0% | 0 | 0 / 0 |
muscle | 33% | 0.64 | 267 / 803 | 0% | 0 | 0 / 0 |
liver | 24% | 0.40 | 54 / 226 | 1% | 0.02 | 3 / 406 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.04 | 1 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007218 | Biological process | neuropeptide signaling pathway |
GO_0007200 | Biological process | phospholipase C-activating G protein-coupled receptor signaling pathway |
GO_0030431 | Biological process | sleep |
GO_0060079 | Biological process | excitatory postsynaptic potential |
GO_0051970 | Biological process | negative regulation of transmission of nerve impulse |
GO_0051971 | Biological process | positive regulation of transmission of nerve impulse |
GO_0046928 | Biological process | regulation of neurotransmitter secretion |
GO_0042594 | Biological process | response to starvation |
GO_0007204 | Biological process | positive regulation of cytosolic calcium ion concentration |
GO_0008156 | Biological process | negative regulation of DNA replication |
GO_0007268 | Biological process | chemical synaptic transmission |
GO_0042755 | Biological process | eating behavior |
GO_0043267 | Biological process | negative regulation of potassium ion transport |
GO_0120162 | Biological process | positive regulation of cold-induced thermogenesis |
GO_0051928 | Biological process | positive regulation of calcium ion transport |
GO_0001659 | Biological process | temperature homeostasis |
GO_0007205 | Biological process | protein kinase C-activating G protein-coupled receptor signaling pathway |
GO_0005576 | Cellular component | extracellular region |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0098794 | Cellular component | postsynapse |
GO_0008021 | Cellular component | synaptic vesicle |
GO_0030141 | Cellular component | secretory granule |
GO_0005791 | Cellular component | rough endoplasmic reticulum |
GO_0031771 | Molecular function | type 1 orexin receptor binding |
GO_0031772 | Molecular function | type 2 orexin receptor binding |
GO_0005184 | Molecular function | neuropeptide hormone activity |
Gene name | HCRT |
Protein name | Hypocretin neuropeptide precursor (Hypocretin) (Hcrt) (Orexin precursor) (Prepro-orexin) (Preprohypocretin) [Cleaved into: Orexin-A (Hypocretin-1) (Hcrt1); Orexin-B (Hypocretin-2) (Hcrt2)] |
Synonyms | PPOX PPORX OX |
Description | FUNCTION: Neuropeptides that play a significant role in the regulation of food intake and sleep-wakefulness, possibly by coordinating the complex behavioral and physiologic responses of these complementary homeostatic functions. A broader role in the homeostatic regulation of energy metabolism, autonomic function, hormonal balance and the regulation of body fluids, is also suggested. .; FUNCTION: [Orexin-A]: Binds to orexin receptors HCRTR1/OX1R and HCRTR2/OX2R with a high affinity (By similarity). Stimulates food intake (By similarity). Modulates pituitary luteinizing hormone secretion in an ovarian steroid-dependent manner (By similarity). .; FUNCTION: [Orexin-B]: Binds to orexin receptor HCRTR2/OX2R only (By similarity). Stimulates food intake (By similarity). Modulates pituitary luteinizing hormone secretion in an ovarian steroid-dependent manner (By similarity). . |
Accessions | O43612 ENST00000293330.1 |